# EDGAR Filing Document

**Accession Number:** 0001873835
**File Stem:** 0001493152-25-025192
**Filing Date:** 2025-11
**Character Count:** 2194
**Document Hash:** 90baf909bd66a97302baca25513563c5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-025192.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001493152-25-025192

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251126

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Immix Biopharma, Inc.
- **CENTRAL INDEX KEY:** 0001873835
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 454869378
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 11400 WEST OLYMPIC BLVD.
- **STREET 2:** SUITE 200
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90064
- **BUSINESS PHONE:** (888) 958-1084

**MAIL ADDRESS:**
- **STREET 1:** 10573 W. PICO BLVD.
- **STREET 2:** #58
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90064

![](formcorresp_001.jpg)

November 26, 2025

---

| | |
|:---|:---|
| Division of Corporation Finance | **VIA EDGAR** |
| U.S. Securities and Exchange Commission |  |
| Washington D.C. 20549 |  |

---

---

| | |
|:---|:---|
| **Re:** | **Immix Biopharma, Inc.** |
|  | **Form S-3 Registration Statement** |
|  | **File No. 333-290725** |

---

**<u>Acceleration Request</u>**

**Request Date**: December 1, 2025

**Request Time**: 4:30 p.m. Eastern Time (or as soon thereafter as practicable)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Immix Biopharma, Inc. (the "<u>Registrant</u>") hereby requests that the United States Securities and Exchange Commission (the "<u>Commission</u>") take appropriate action to cause the above-captioned Registration Statement (the "<u>Registration Statement</u>") to become effective at 4:30 p.m. Eastern Standard Time, Monday, December 1, 2025, or as soon thereafter as practicable.

Please contact Mr. David M. Loev of The Loev Law Firm, PC at (832) 930-6432, with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.

---

| |
|:---|
| Very truly yours, |
| */s/ Gabriel Morris* |
| Gabriel Morris |
| Chief Financial Officer |

---